Brief: Lee's Pharmaceutical Sees HY Net Profit Between Hk$31.4-44.0 Mln
13/08/2019 12:16
Aug 13 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* EXPECTED TO RECORD AN UNAUDITED NET PROFIT OF BETWEEN
HK$31.44
MILLION AND HK$44.02 MILLION FOR SIX MONTHS
* EXPECTED RESULT DUE TO NON-RECURRING LOSS OF
APPROXIMATELY
HK$108 MILLION INCURRED BY CHINA ONCOLOGY FOCUS
Source text for Eikon: ID:nHKS4zqwPV
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals